Geographic Excess of Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 12, 2003, Pages 1523-1527

  Benz, Christopher C ^a,b   Clarke, Christina A ^c   Moore II, Dan H ^b,d  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOCIAL STATUS; UNITED STATES; URBAN AREA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CALIFORNIA; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MIDDLE AGED; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; RECEPTORS, ESTROGEN; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 0346102476     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Willett, W. C., Rockhill, B., Hankinson, S. E., Hunter, D. J., and Colditz, G. A. Epidemiology and nongenetic causes of breast cancer. In: J. R. Harris, M. E. Lippman, M. Morrow, and C. K. Osborne (eds.), Diseases of the Breast, pp. 175-220. Philadelphia: Lippincott Williams & Wilkins, 2000.
2. Lacey, J. V., Jr., Devesa, S. S., and Brinton, L. A. Recent trends in breast cancer incidence and mortality. Environ. Mol. Mutagen., 39: 82-88, 2002.
3. West, D. W., and Davis, T. E. Breast cancer incidence among women in the San Francisco and Monterey Bay areas. Greater Bay Area Cancer Registry Report, 3: 1-4, 1991.
4. Prehn, A. W., and West, D. W. Evaluating local differences in breast cancer incidence rates: a census-based methodology (United States). Cancer Causes Control, 9: 511-517, 1998.
5. Prehn, A. W., Clarke, C., Topol, B., Glaser, S., and West, D. Increase in breast cancer incidence in middle-aged women during the 1990s. Ann. Epidemiol., 12: 476-481, 2002.
6. Clarke, C. A., Glaser, S. L., West, D. W., Ereman, R. R., Erdmann, C. A., Barlow, J. M., and Wrensch, M. R. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999. Breast Cancer Res., 4: R13, 2002.
7. Wrensch, M., Chew, T., Farren, G., Barlow, J., Belli, F., Clarke, C., Erdmann, C. A., Lee, M., Moghadassi, M., Peskin-Mentzer, R., Quesenberry, C. P., Souders-Mason, V., Spence, L., Suzuki, M., and Gould, M. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res., 5: R88-R102, 2003.
8. Li, C. I., Anderson, B. O., Daling, J. R., and Moe, R. E. Trends in incidence rates of invasive lobular and ductal breast carcinoma. J. Am. Med. Assoc., 289: 1421-1424, 2003.
9. Li, C. I., Weiss, N. S., Stanford, J. L., and Daling, J. R. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (Phila.), 88: 2570-2577, 2000.
10. Stierer, M., Rosen, H., Weber, R., Hanak, H., Spona, J., and Tuchler, H. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer: correlation of histopathology and prognostic factors. Ann. Surg., 218: 13-21, 1993.
11. Quong, J., Eppenberger-Castori, S., Moore, D., II, Scott, G. K., Birrir, M. J., Kueng, W., Eppenberger, U., and Benz, C. C. Age-dependent changes in breast cancer hormone receptors and oxidant stress markeis. Breast Cancer Res. Treat., 76: 221-236, 2002.
12. Chu, K. C., and Anderson, W. F. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res. Treat., 74: 199-211, 2002.
13. Gordon, N. H. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev., 22: 55-65, 2003.
14. Britton, J. A., Gammon, M. D., Schoenberg, J. B., Stanford, J. L., Coates, R. J., Swanson, C. A., Potischman, N., Malone, K. E., Brogan, D. J., Daling, J. R., and Brinton, L. A. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am. J. Epidemiol., 156: 507-516, 2002.
15. Bernstein, L., Allen, M., Anton-Culver, H., Deapen, D., Horn-Ross, P. L., Peel, D., Pinder, R., Reynolds, P., Sullivan-Halley, J., West, D., Wright, W., Ziogas, A., and Ross, R. K. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control, 13: 625-635, 2002.
16. Loman, N., Johannsson, O., Bendahl, P. O., Borg, A., Ferno, M., and Olsson, H. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer (Phila.), 83: 310-319, 1998.
17. Li, C. I., Malone, K. E., and Daling, J. R. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol. Biomark. Prev., 11: 601-607, 2002.
18. Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., and Cummings, S. R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of osteoporotic fractures research group. Ann. Intern. Med., 130: 270-277, 1999.
19. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. (Bethesda), 94: 606-616, 2002.
20. Lippman, M. E., Krueger, K. A., Eckert, S., Sashegyi, A., Walls, E. L., Jamal, S., Cauley, J. A., and Cummings, S. R. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the Multiple Outcomes of Raloxifene Evaluation study participants. J. Clin. Oncol., 19: 3111-3116, 2001.
21. Beral, V., Banks, E., and Reeves, G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet, 360: 942-944, 2002.
22. Cobleigh, M. A., Norlock, F. E., Oleske, D. M., and Starr, A. Hormone replacement therapy and high S phase in breast cancer. J. Am. Med. Assoc., 281: 1528-1530, 1999.
23. Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., Khandekar, J., Petrovitch, H., McTieman, A., and Women's Health Initiative Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. J. Am. Med. Assoc., 289: 3243-3253, 2003.
24. Li, C. I., Malone, K. E., Porter, P. L., Weiss, N. S., Tang, M-T., Cushing-Haugen, K. L., and Daling, J. R. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. J. Am. Med. Assoc., 289: 3254-3263, 2003.
25. Miller, B. A., Hankey, B. F., and Thomas, T. L. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am. J. Epidemiol., 155: 534-545, 2002.
26. Brawley, O. W. Disaggregating the effects of race and poverty on breast cancer outcomes. J. Natl. Cancer Inst. (Bethesda), 94: 471-473, 2002.
27. Gordon, N. H. Association of education and income with estrogen receptor status in primary breast cancer. Am. J. Epidemiol., 142: 796-803, 1995.
28. Thomson, C. S., Hole, D. J., Twelves, C. J., Brewster, D. H., and Black, R. J., on behalf of the Scottish Cancer Therapy Network. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J. Epidemiol. Commun. Health, 55: 308-315, 2001.
29. California Department of Health Services, Office of Women's Health. Data Points: Results from the 1997 Women's Health Survey: Menopause Related Symptoms and Use of Medical Care to Treat Them. Issue I, Number 23, 1999.
30. County of Marin, Department of Health and Human Services. Marin Community Health Survey: Breast Cancer Risk Factors in Marin County Women, 2001. Vol. 1, Issue I. May 2003.
31. Singletary, K. W., and Gapstur, S. M. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. J. Am. Med. Assoc., 286: 2143-2151, 2001.
32. Chen, W. Y., Colditz, G. A., Rosner, B., Hankinson, S. E., Hunter, D. J., Manson, J. E., Stampfer, M. J., Willett, W. C., and Speizer, F. E. Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann. Intern. Med., 137: 798-804, 2002.
33. Singletary, K. W., Frey, R. S., and Yan, W. Effect of ethanol on proliferation and estrogen receptor-α expression in human breast cancer cells. Cancer Lett., 165: 131-137, 2001.
34. Enger, S. M., Ross, R. K., Paganini-Hill, A., Longnecker, M. P., and Bernstein, L. Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br. J. Cancer, 79: 1308-1314, 1999.
35. Sellers, T. A., Vierkant, R. A., Cerhan, J. R., Gapstur, S. M., Vachon, C. M., Olson, J. E., Pankratz, V. S., Kushi, L. H., and Folsom, A. R. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol. Biomark. Prev., 11: 1104-1107, 2002.